FagliaG, ContiA, MuratoriM, TogniE, TravagliniP, ZanottiA, MaillandFDihydroegokriptine in management of microprolactinoma.J. Clin. Endocrinol. Metab.65: 779–84, 1987.
3.
MoosRHThe development of a Menstrual Distress Questionnaire.Psychosom. Med., 30: 853–66, 1968.
4.
CanonicoPL, ScapagniniU, GenazzaniE, ZanottiADihydroergokryptine (DEK) in the prophylaxis of common migraine: double-blind clinical study vs placebo.Cephalalgia 9, Suppl10: 446–447, 1989.
